What is the address of Dr. Sarah Jeurissen, Oncologie?

The registered office of Dr. Sarah Jeurissen, Oncologie is located at Korrestraat 27, 9550 Herzele.

Is Dr. Sarah Jeurissen, Oncologie still active?

Yes. According to the CBE (18 September 2026) Dr. Sarah Jeurissen, Oncologie is active, legal situation “Normale toestand”, started on 18 May 2021.

Is Dr. Sarah Jeurissen, Oncologie registered on Peppol?

Yes, Dr. Sarah Jeurissen, Oncologie is registered on the Peppol network with ID 0208:0768493881.

What is the enterprise number of Dr. Sarah Jeurissen, Oncologie?

The enterprise number of Dr. Sarah Jeurissen, Oncologie is BE0768493881.

When was Dr. Sarah Jeurissen, Oncologie founded?

Dr. Sarah Jeurissen, Oncologie was founded on 18 May 2021.

Who are the directors of Dr. Sarah Jeurissen, Oncologie?

According to the 2025 annual accounts, the directors of Dr. Sarah Jeurissen, Oncologie are: Sarah JEURISSEN.

Is Dr. Sarah Jeurissen, Oncologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 18 May 2021; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Sarah Jeurissen, Oncologie make in 2025?

Dr. Sarah Jeurissen, Oncologie posted a profit after taxes of € 27,728 in financial year 2025.

What is the revenue of Dr. Sarah Jeurissen, Oncologie?

As a small company, Dr. Sarah Jeurissen, Oncologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 55,871.

Dr. Sarah Jeurissen, Oncologie (Private Limited)

Dossier Dr. Sarah Jeurissen, Oncologie, printed on 18 September 2026 from databakkes.be/en/0768493881/dr-sarah-jeurissen-oncologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Sarah Jeurissen, Oncologie from Herzele, company number BE0768493881, closed financial year 2025 with a result of € 27,728 after tax. For that financial year Dr. Sarah Jeurissen, Oncologie recorded a gross margin of € 55,871 and equity of € 9,367. Compared with financial year 2024, the result moved from € 42,626 to € 27,728. The company is profitable. The buffer shrank hard: equity is 86 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on April 13, 2026.

What it is worth Shrank hard

€ 9,367

▼ 86% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 27,728

▼ 35% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 73,121

▼ 19% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 85,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 37,546

▼ 30% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 33,905

▼ 31% vs 2024

€ 15,371 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 5,419

▲ 184% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 22,812

▲ 23% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 14,349 Gross margin 2022: € 14,349 First fiscal year in the series	€ 29,196 Gross margin 2023: € 29,196 ▲ 103% vs 2022 (€ 14,349) Favourable step	€ 73,348 Gross margin 2024: € 73,348 ▲ 151% vs 2023 (€ 29,196) Favourable step	€ 55,871 Gross margin 2025: € 55,871 ▼ 24% vs 2024 (€ 73,348) Unfavourable step	▼ 24%
Profit after taxes	€ 11,093 Profit after taxes 2022: € 11,093 First fiscal year in the series	€ 8,920 Profit after taxes 2023: € 8,920 ▼ 20% vs 2022 (€ 11,093) Unfavourable step	€ 42,626 Profit after taxes 2024: € 42,626 ▲ € 33,707 vs 2023 (€ 8,920) Favourable step	€ 27,728 Profit after taxes 2025: € 27,728 ▼ 35% vs 2024 (€ 42,626) Unfavourable step	▼ 35%
Equity	€ 15,093 Equity 2022: € 15,093 First fiscal year in the series	€ 24,013 Equity 2023: € 24,013 ▲ 59% vs 2022 (€ 15,093) Favourable step	€ 66,639 Equity 2024: € 66,639 ▲ 178% vs 2023 (€ 24,013) Favourable step	€ 9,367 Equity 2025: € 9,367 ▼ 86% vs 2024 (€ 66,639) Unfavourable step	▼ 86%
Total debts	€ 10,497 Total debts 2022: € 10,497 First fiscal year in the series	€ 76,909 Total debts 2023: € 76,909 ▲ € 66,413 vs 2022 (€ 10,497) Unfavourable step	€ 76,976 Total debts 2024: € 76,976 Unchanged (€ 76,909) Unfavourable step	€ 117,706 Total debts 2025: € 117,706 ▲ 53% vs 2024 (€ 76,976) Unfavourable step	▲ 53%
Cash	€ 25,590 Cash 2022: € 25,590 First fiscal year in the series	€ 29,403 Cash 2023: € 29,403 ▲ 15% vs 2022 (€ 25,590) Favourable step	€ 90,010 Cash 2024: € 90,010 ▲ 206% vs 2023 (€ 29,403) Favourable step	€ 73,121 Cash 2025: € 73,121 ▼ 19% vs 2024 (€ 90,010) Unfavourable step	▼ 19%
Retained profit	€ 11,093 Retained profit 2022: € 11,093 First fiscal year in the series	€ 20,013 Retained profit 2023: € 20,013 ▲ 80% vs 2022 (€ 11,093) Favourable step	€ 62,639 Retained profit 2024: € 62,639 ▲ 213% vs 2023 (€ 20,013) Favourable step	€ 5,367 Retained profit 2025: € 5,367 ▼ 91% vs 2024 (€ 62,639) Unfavourable step	▼ 91%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 85,000 Dividend 2025: € 85,000 Unchanged (€ 0) Unchanged
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 63,279 Bank debt 2023: € 63,279 Unchanged (€ 0) Unfavourable step	€ 48,816 Bank debt 2024: € 48,816 ▼ 23% vs 2023 (€ 63,279) Favourable step	€ 33,905 Bank debt 2025: € 33,905 ▼ 31% vs 2024 (€ 48,816) Favourable step	▼ 31%
Balance sheet total	€ 25,590 Balance sheet total 2022: € 25,590 First fiscal year in the series	€ 100,922 Balance sheet total 2023: € 100,922 ▲ 294% vs 2022 (€ 25,590) Unchanged	€ 143,615 Balance sheet total 2024: € 143,615 ▲ 42% vs 2023 (€ 100,922) Unchanged	€ 127,073 Balance sheet total 2025: € 127,073 ▼ 12% vs 2024 (€ 143,615) Unchanged	▼ 12%

Key figures of Dr. Sarah Jeurissen, Oncologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Sarah Jeurissen, Oncologie?

What happened at Dr. Sarah Jeurissen, Oncologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 13, 2026 New annual accounts for financial year 2025: profit of € 27,728 (▼ 35% vs 2024). Source: NBB ↗
May 18, 2021 New establishment in Herzele. KBO
May 18, 2021 Start of the company according to the CBE. KBO

In short

From € 11,093 profit in 2022 to € 27,728 profit in 2025.

Paid € 24,547 in corporate taxes since 2022.

Best year ever: 2024, with € 42,626 profit.

Paid out € 85,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Sarah Jeurissen, Oncologie? We notify you, reason included.

Follow Dr. Sarah Jeurissen, Oncologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit